Download slides from our live symposium with Drs. Atkins, Plimack, and Rini on the latest clinical data for treating patients with renal cell carcinoma.
Dr. Celestia (Tia) S. Higano reviews clinically relevant mutations in prostate cancer and outlines who should receive genetic testing and counseling.
David A. Quigley, PhD, reviews clinically relevant DNA repair mutations and their implications for patients with advanced prostate cancer.
Charles J. Ryan, MD, reviews the latest clinical evidence for PARP inhibition in the care of patients with advanced prostate cancer.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.